SCHEMBL24309744

SCHEMBL24309744

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCNCC3)cc2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 4/20 0.38
▸ LCK P06239 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ TNK2 Q07912 1/20 0.34
▸ HTR7 P34969 2/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ IGF1R P08069 2/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ACVR1 Q04771 2/20 0.33
▸ HTR3E A5X5Y0 1/20 0.32
▸ HTR3B O95264 1/20 0.32
▸ ADRB1 P08588 1/20 0.32
▸ HTR3A P46098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309902 0.91 IGF1R (0.37) LTA4HLCKJAK3BTKTNK2
SCHEMBL24309862 0.87 TNK2 (0.32) BTKTNK2IGF1R
SCHEMBL24310025 0.86 TNK2 (0.35) LTA4HLCKJAK3BTKTNK2
SCHEMBL24309676 0.84 FLT3 (0.38) LTA4HHTR7HTR1AIGF1RCYP1A2
SCHEMBL24310424 0.84 PDE2A (0.41) JAK3IGF1RCDK6CCNKCCNA2
SCHEMBL24310428 0.84 MAP4K1 (0.38) JAK3TNK2IGF1RCDK6CCNK
SCHEMBL24310158 0.83 MAP4K1 (0.37) JAK3TNK2IGF1RCDK6CCNK
SCHEMBL24309830 0.82 IGF1R (0.32) IGF1R
SCHEMBL24309719 0.82 MAP4K1 (0.37) JAK3TNK2IGF1RCDK6CCNK
SCHEMBL24309882 0.82 MAP4K1 (0.37) JAK3TNK2IGF1RCDK6CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback